Menopause
Link between fatty liver disease, hot flash severity ‘hard to tease apart’
Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or very severe hot flashes, though researchers found no direct link between the two conditions, data show.
LGBTQ+ women veterans report fewer midlife sexual dysfunction symptoms
Heterosexual midlife women veterans reported more sexual dysfunction and impact from vaginal symptoms and were less likely to be sexually active compared with sexual minority counterparts, according to findings published in Menopause.
VIDEO: Menopause can contribute to loss of natural tears, dry eye symptoms
CHICAGO — In this Healio Video Perspective from the AAO meeting, Sheri Rowen, MD, of NVISION Eye Centers, discusses the link between dry eye disease and menopause.
Q&A: New stroke guidance highlights risk for women with endometriosis, early menopause
New guidance on primary prevention of stroke from the American Heart Association and American Stroke Association states women with endometriosis and early menopause are at higher risk, requiring a thorough history and tailored management.
FDA adds boxed warning to hot flash drug Veozah due to liver injury risk
The FDA added a boxed warning to highlight known risk for rare but serious liver injury associated with the use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, according to an agency press release.
Early menopause tied to higher risk for incident heart failure
Women with menopause onset before age 45 years were more likely to develop incident heart failure regardless of serum adipokine levels, according to study findings published in Menopause.
CV risks vary based on menopausal hormone therapy combinations, administration methods
Cardiovascular disease risks vary depending on the type of menopausal hormone therapy combinations and administration methods used, according to a nationwide trial published in The BMJ.
No cognitive impact 10 years after short-term, early menopausal hormone therapy: KEEPS
Short-term exposure to hormone therapy started within 3 years of menopause was not associated with long-term cognitive impairment or benefit, according to data from the KEEPS Continuation study.
VIDEO: Mount Sinai conference spotlights latest treatments, wellness for midlife women
In this Healio video exclusive, Joanne Stone, MD, MS, and Susan S. Khalil, MD, discussed highlights from the second annual Mount Sinai Women’s Health Forum, a 1-day conference dedicated to the latest updates in care for midlife women.
Older age at natural menopause may increase asthma risk
Later age at natural menopause may be a risk factor for asthma, potentially due to prolonged estrogen exposure, data from a longitudinal study show.